Table 5 Indication and resulting oncological therapy in patients with a malignant primary disease in a hospice
From: Use of symptom-focused oncological cancer therapies in hospices: a retrospective analysis
Oncological disease | Indication oncological therapy (H1) | Oncological therapya (H1) | Indication oncological therapy (H2) | Oncological therapya (H2) |
|---|---|---|---|---|
Bronchial carcinomas | Bone pain | Bisphosphonates (n = 3), Radiation (n = 1) | Continuation of ongoing therapy | Tyrosine kinase inhibitor (n = 1) |
Meningeal cancer manifestation | Intrathecal chemotherapy (n = 1) | none | none | |
Dyspnea due to cancer disease | Intravenous chemotherapy (n = 1) | none | none | |
Gastrointestinal cancers | Bone pain | Bisphosphonates (n = 1) | none | none |
Dyspnea due to anaemia | Erythrocyte transfusion (n = 4) | none | none | |
Diarrhea due to cancer disease | Somatostatin analogues (n = 2) | none | none | |
Complications due to peritoneal carcinomatosis | Tyrosine kinase inhibitor (n = 1) | none | none | |
Gynecological cancers | Bone pain | Bisphosphonates (n = 4), Radiation (n = 1), Anti-hormonal therapy (n = 2) | Bone pain | Bisphosphonates (n = 2) |
Pain therapy | Anti-hormonal therapy (n = 2) | Pain therapy | Anti-hormonal therapy (n = 2) | |
Dyspnea due to anaemia | Erythrocyte transfusion (n = 2) | none | none | |
Nausea/vomiting due to cancer disease | Somatostatin analogues (n = 1) | none | none | |
Brain cancers | Complications due to brain cancer | Oral chemotherapy (n = 1) Radiation (n = 1) | Continuation of ongoing therapy | Tyrosine kinase inhibitor (n = 1) |
ENT tract cancers | Dyspnea due to anaemia | Erythrocyte transfusion (n = 1) | none | none |
Other cancer (bone cancers, thyroid carcinomas, skin malignomas, cancer of unknown pirmary) | none | none | none | none |
Urological cancers | Bone pain | Bisphosphonates (n = 2), Radiation (n = 2) | none | none |
Dyspnea due to anaemia | Erythrocyte transfusion (n = 1) | none | none | |
Pain therapy | Radiation (n = 1), Anti-hormonal therapy (n = 1) | none | none | |
Hematological systemic diseases | Complications due to leukocytosis | Oral/subcutaneous chemotherapy (n = 3) | none | none |
Dyspnea due to anaemia | Erythrocyte transfusion (n = 2) | none | none |